CDH1 and cancer: The epithelial-to-mesenchymal transition (EMT) is an acute event in cancer metastasis, characterized by reciprocal loss of expression of epithelial cell-associated proteins, such as E-cadherin, and increased levels of mesenchymal markers, such as vimentin [56,57].